ストックスクリーナーアプリを入手
10.49
5.41%
-0.60
プレマーケット:
10.71
0.22
+2.10%
前日終値:
$11.09
開ける：
$10.29
24時間の取引高:
4.97M
Relative Volume:
2.67
時価総額：
$1.37B
収益：
$745.97M
当期純損益:
$-99.21M
株価収益率:
-13.57
EPS:
-0.7729
ネットキャッシュフロー:
$-5.09M
1週間 パフォーマンス:
-8.30%
1か月 パフォーマンス:
+27.31%
6か月 パフォーマンス:
-10.11%
1年 パフォーマンス:
+41.57%
1日の値動き範囲:
$10.05
$11.04
1週間の範囲:
$10.05
$11.82
52週間の値動き範囲:
$4.72
$13.74
Neogenomics Inc Stock (NEO) Company Profile
Compare NEO vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
10.49 | 1.44B | 745.97M | -99.21M | -5.09M | -0.7729 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics launches $275M convertible notes offering due 2032 - MSN
NeoGenomics launches $275M convertible notes offering By Investing.com - Investing.com South Africa
NeoGenomics launches $275M convertible notes offering - Investing.com
NeoGenomics Reports Convertible Notes Offering - marketscreener.com
NeoGenomics launches $275M convertible notes offering due 2032 with $41.25M overallotment option - TradingView
NeoGenomics (NASDAQ: NEO) launches $275M 2032 convertible notes and buyback plan - Stock Titan
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes - Business Wire
Lynn Tetrault sells 5,307 NEO shares under 10b5-1 (NASDAQ: NEO) - Stock Titan
NEO News | NEOGENOMICS INC (NASDAQ:NEO) - ChartMill
Neogenomics (NEO) director sells 5,307 shares, retains sizable stake - Stock Titan
[144] NEOGENOMICS INC SEC Filing - Stock Titan
NeoGenomics (NEO) Q1 2025 Earnings Transcript - AOL.com
(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NeoGenomics (NEO) director gains RSU grants and stock options, exercises awards - Stock Titan
Felicia Williams (NASDAQ: NEO) gains shares via RSUs and options - Stock Titan
NeoGenomics (NEO) director boosts holdings through option and RSU awards - Stock Titan
NeoGenomics (NASDAQ: NEO) director exercises RSUs and gains new options - Stock Titan
NeoGenomics (NEO) director adds shares via RSU release and new options - Stock Titan
NeoGenomics (NEO) director exercises 23,077 RSUs and receives new option, RSU grants - Stock Titan
NeoGenomics (NEO) director adds 23,077 shares through RSU vesting - Stock Titan
NeoGenomics (NEO) director reports RSU release and new stock option grants - Stock Titan
NeoGenomics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 6, 2023 to Discuss Your RightsNEO - TMX Newsfile
NeoGenomics Inc (NEO) Stock Up 6.5% and Still Undervalued -- GF Score: 68/100 - GuruFocus
William Blair Maintains NeoGenomics(NEO.US) With Hold Rating - Moomoo
Is NeoGenomics (NEO) Using Its ASCO ctDNA Focus To Redefine Its Precision Oncology Edge? - Yahoo Finance
NeoGenomics Inc. (NEO) Edges Higher as Stock Hovers Near Support in a Consolidative PhaseForce Index - The Legal Advocate
NeoGenomics to Present New Research at ASCO Annual Meeting 2026 - Business Wire
NeoGenomics Inc. (NEO) Edges Higher as Diagnostic Sector Shows Renewed InterestBull Pennant - The Legal Advocate
(NEO) Risk Channels and Responsive Allocation - Stock Traders Daily
NeoGenomics Investor Alert - TMX Newsfile
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $11 to $25 - Moomoo
Shareholders approve NeoGenomics (NASDAQ: NEO) equity plan amendment and board slate - Stock Titan
NeoGenomics Earnings Call Highlights NGS-Driven Momentum - TipRanks
NeoGenomics stock (US64049M2098): Q1 update keeps focus on cancer testing demand - AD HOC NEWS
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance
NEOGENOMICS (NEO) 13G/A: Greenhouse reports 9,215,903 shares (7.1%) - Stock Titan
NeoGenomics signals $797M-$803M 2026 revenue outlook following PanTracer Liquid MolDX approval - MSN
Oncology diagnostics group NeoGenomics meets investors at May, June conferences - Stock Titan
NeoGenomics to Participate in Upcoming Investor Conferences - The Joplin Globe
(NEO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
This NeoGenomics Insider Reduced Their Stake By 15% - Moomoo
Millennium group reports 2.22M NEO shares (1.7%) — Joint filing (NEO) - Stock Titan
NeoGenomics (NEO) EVP adds shares via RSU vesting while covering taxes - Stock Titan
NeoGenomics (NEO) COO exercises RSUs, withholds shares for taxes and holds 164,032 shares - Stock Titan
TradingKey - TradingKey
Is NeoGenomics’ Higher 2026 Revenue Outlook And Narrower Loss Profile Altering The Investment Case For NEO? - Sahm
NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
NeoGenomics Inc. (NEO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
NeoGenomics to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, July 23, 2015 - ACCESS Newswire
NEO PE Ratio & Valuation, Is NEO Overvalued - Intellectia AI
First Light, Mathew Arens report 10.8% stakes in Neogenomics (NEO) - Stock Titan
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
Neogenomics Inc (NEO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TETRAULT LYNN A. | Director |
Jun 09 '26 |
Sale |
11.29 |
5,307 |
59,916 |
91,422 |
0.56%
0.44%
大文字化:
|
ボリューム (24 時間):